Pharma: Other News To Note
Monday, June 18, 2012
Meda AB, of Goteborg, Sweden, reported that Edluar has received registration approval in Europe, via the decentralization process, to treat sleep disorders. National registration processes will follow in each country, with the first launches expected early next year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.